NASDAQ: FENC - Fennec Pharmaceuticals Inc.

六个月盈利: +3.15%
股息率: 0.00%
部门: Healthcare

促销时间表 Fennec Pharmaceuticals Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company's product candidates include PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2001-06-05
ISIN CA31447P1009
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.fennecpharma.com
Цена ао 10.89
每日价格变化: -2.35% (6.37)
每周价格变化: +3.84% (5.99)
每月价格变化: +3.49% (6.01)
3个月内价格变化: +19.62% (5.2)
六个月内的价格变化: +3.15% (6.03)
每年价格变化: -44.56% (11.22)
3年内价格变化: +47.74% (4.21)
5年内价格变化: +7.06% (5.81)
10年价格变化: 0% (6.22)
年初以来价格变化: +3.49% (6.01)
所有参数

低估

姓名 意义 年级
P/S 13.46 1
P/BV -25.19 0
P/E 0 0
EV/EBITDA -23.65 0
全部的: 2.88

效率

姓名 意义 年级
ROA, % -61.13 0
ROE, % 141.31 10
全部的: 3.33

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -2.38 10
全部的: 9.6

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 3219999900 10
盈利能力 Ebitda, % -4.89 0
盈利能力 EPS, % -3.27 0
全部的: 4.6
更多详情

机构 体积 分享, %
Southpoint Capital Advisors LP 4077214 15.04
Sonic Gp LLC 2407357 8.88
Solas Capital Management, LLC 1378513 5.09
Avoro Capital Advisors LLC 1200000 4.43
Vanguard Group Inc 1140063 4.21
DG Capital Management, LLC 1075634 3.97
Blackrock Inc. 934591 3.45
Harbert Fund Advisors, Inc. 466869 1.72
AIGH Capital Management LLC 329370 1.22
Gendell, Jeffrey L. 282478 1.04



导师 职称 支付 出生年份
Mr. Rostislav Raykov CEO & Director 885.07k 1976 (49 年)
Mr. Robert C. Andrade Chief Financial Officer 600.88k 1975 (50 年)
Mr. Lei Fang President of Pharstat Inc N/A
Mr. Mark Gowland Controller

地址: United States, Research Triangle Park. NC, 68 TW Alexander Drive - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.fennecpharma.com